Pharma Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Brown University, U.S.
Self-report symptom scale for identifying depression remission validated
July 4th, 2006
Scientists have validated a self-report depression symptom scale for identifying remission in depressed outpatients. According to a study from the United States, "In treatment studies of depression, remission is usually defined by scoring less than a threshold value on an interview-based measure of depression severity such as the Hamilton Rating Scale for Depression (HRSD). Although it has been recommended that measures such as the HRSD be used by clinicians in clinical practice to evaluate remission status, the time demands of clinical practice limit the feasibility of this suggestion." "Self-report questionnaires are a cost-effective option to...
Source: Pharma Law Weekly (2006-07-04)
|
